Effect of SARS-CoV-2 IgG Seroconversion After Convalescent Plasma Transfusion on Hospital Outcomes in COVID-19
Sonal Pannu(Oklahoma City University), Jeffrey C. Horowitz(Lung Institute), Rama K. Mallampalli(The Ohio State University), Scott Scrape(The Ohio State University), Michael H. Cardone(The Ohio State University), Shan‐Lu Liu(The Ohio State University), Mohankumar Doraiswamy(University of Arkansas – Fort Smith), Matthew C. Exline(The Ohio State University), Ma Jianing(The Ohio State University), Jing Peng(Harvard University), Gerald Lozanski(The Ohio State University), Michael F. Para(The Ohio State University)
Cited by 1
Related Papers
IFITM Proteins Restrict Viral Membrane Hemifusion
|PLoS Pathogens|2013|370
Extracellular matrix in lung development, homeostasis and disease
|Matrix Biology|2018|290
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
|Cell Host & Microbe|2022|280
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
|American Journal of Respiratory and Critical Care Medicine|2013|247